On 30 November 2015 Dr LM Hofmeyr and Dr Johan Nel (ENT) performed the first BONEBRIDGE active bone conduction system for hearing loss at the Louis Leipoldt Mediclinic. This is the world’s first active bone conduction implant system for hearing loss. It can be offered for different types of hearing loss. Indications include chronic infections, malformations and other causes of conductive and mixed hearing loss. It is also an option for individuals with single-sided deafness.
With conductive or mixed hearing loss, sound cannot take the natural path through the outer and middle ear to the inner ear. With the BONEBRIDGE, the sound waves are transmitted via bone conduction directly to the inner ear, where they are processed as natural sound. This implant ensures optimal daily hearing performance. It is implanted under the skin, remaining discreet and unobtrusive.
The BONEBRIDGE is an innovative new bone conduction implant that transmits sound waves via the cranial bone directly to the inner ear, where they are perceived as natural sound.